Advertisement

Advertisement

NCCN 2022 Annual Conference

issues in oncology
survivorship

Maria Alma Rodriguez, MD, on Vaccinations for Patients With Cancer and Cancer Survivors

Maria Alma Rodriguez, MD, of The University of Texas MD Anderson Cancer Center, discusses the need for various types of vaccinations in patients with cancer, who are vulnerable to infection while unde...

lymphoma

Ann S. LaCasce, MD, MMSc, on Relapsed/Refractory Indolent Follicular Lymphoma: Management Updates

Ann S. LaCasce, MD, MMSc, of Dana-Farber Cancer Institute, discusses the various agents available to treat patients with indolent B-cell lymphomas: lenalidomide plus rituximab, which has a superior pr...

skin cancer
immunotherapy

Genevieve Boland, MD, PhD, on Advanced Melanoma: Best Management Practices

Genevieve Boland, MD, PhD, of Massachusetts General Hospital Cancer Center, discusses targeted treatments and immunotherapies and how they have dramatically changed the landscape in melanoma. Initiall...

Colorectal Cancer

Changes in the NCCN Guidelines on Colorectal Cancer Screening

The National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology: Colorectal Cancer Screening have recently incorporated significant changes, reflecting recommendations that...

colorectal cancer

Reid M. Ness, MD, MPH, on Colorectal Cancer: Updates in Screening Recommendations

Reid M. Ness, MD, MPH, of Vanderbilt-Ingram Cancer Center, discusses significant updates to the NCCN Clinical Practice Guidelines in Oncology for colorectal cancer screening: lowering the age from 50 ...

bladder cancer

Thomas W. Flaig, MD, on Bladder Cancer: New Treatment Options

Thomas W. Flaig, MD, of the University of Colorado Cancer Center, discusses the rapidly changing treatment landscape for patients with bladder cancer, including PD-1 and PD-L1 inhibitors now approved ...

pancreatic cancer

Margaret A. Tempero, MD, on Pancreatic Adenocarcinoma: Emerging Systemic Therapy Options

Margaret A. Tempero, MD, of the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the most effective ways to use the regimens available to treat patien...

prostate cancer

Julio M. Pow-Sang, MD, on Nonmetastatic Prostate Cancer: Update on Best Management Practices

Julio M. Pow-Sang, MD, of Moffitt Cancer Center, discusses the treatment landscape for localized prostate cancer and its heterogeneity, the critical importance of stratifying risk to determining treat...

Advertisement

Advertisement



Advertisement